0001237899-12-000090.txt : 20121130
0001237899-12-000090.hdr.sgml : 20121130
20121130134731
ACCESSION NUMBER: 0001237899-12-000090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121128
FILED AS OF DATE: 20121130
DATE AS OF CHANGE: 20121130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VAGELOS P ROY
CENTRAL INDEX KEY: 0001013064
STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721]
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 121234032
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-11-28
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001013064
VAGELOS P ROY
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
Chairman of the Board
Common Stock
2012-11-28
4
S
0
7004.0
175.03
D
135576.0
D
Common Stock
2012-11-29
4
S
0
1800.0
175.95
D
133776.0
D
Common Stock
2012-11-29
4
S
0
5100.0
176.54
D
128676.0
D
Common Stock
2012-11-29
4
S
0
4402.0
177.09
D
124274.0
D
Common Stock
2012-11-29
4
S
0
18440.0
178.71
D
105834.0
D
Common Stock
2012-11-29
4
S
0
19733.0
179.6
D
86101.0
D
Common Stock
2012-11-29
4
S
0
12000.0
180.59
D
74101.0
D
Common Stock
2012-11-29
4
S
0
17155.0
181.19
D
56946.0
D
Common Stock
82410.0
I
by GRAT
Common Stock
2329.0
I
By 401(k) Plan
Common Stock
162657.0
I
by CLAT
Common Stock
15162.0
I
by GRAT
Common Stock
3.0
I
by GRAT
Common Stock
127500.0
I
by Spouse as Trustee
Common Stock
1203.0
I
by trust for grandch
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 7,004 shares of Company stock on November 28, 2012 at prices ranging from $175.00 to $175.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 28, 2012 at each separate price.
Represents volume-weighted average price of sales of 1,800 shares of Company stock on November 29, 2012 at prices ranging from $175.45 to $175.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
Represents volume-weighted average price of sales of 5,100 shares of Company stock on November 29, 2012 at prices ranging from $176.00 to $176.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
Represents volume-weighted average price of sales of 4,402 shares of Company stock on November 29, 2012 at prices ranging from $177.00 to $177.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
Represents volume-weighted average price of sales of 18,440 shares of Company stock on November 29, 2012 at prices ranging from $178.51 to $178.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
Represents volume-weighted average price of sales of 19,733 shares of Company stock on November 29, 2012 at prices ranging from $179.00 to $179.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
Represents volume-weighted average price of sales of 12,000 shares of Company stock on November 29, 2012 at prices ranging from $180.00 to $180.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
Represents volume-weighted average price of sales of 17,155 shares of Company stock on November 29, 2012 at prices ranging from $181.00 to $181.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
/s/**P. Roy Vagelos
2012-11-30